Medical Care Research and Review

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

The Diabetes Educator

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spence, M. M.
Right arrow Articles by Millares, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spence, M. M.
Right arrow Articles by Millares, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Medical Care Research and Review, Vol. 62, No. 5, 544-559 (2005)
DOI: 10.1177/1077558705279314
© 2005 SAGE Publications

Direct-to-Consumer Advertising of COX-2 Inhibitors: Effect on Appropriateness of Prescribing

Michele M. Spence

Kaiser Permanente

Stephanie S. Teleki

RAND

T. Craig Cheetham

Kaiser Permanente

Stuart O. Schweitzer

University of California, Los Angeles

Mirta Millares

Kaiser Permanente

Spending on direct-to-consumer advertising (DTCA) of prescription drugs has increased dramatically in the past several years. An unresolved question is whether such advertising leads to inappropriate prescribing. In this study, the authors use survey and administrative data to determine the association of DTCA with the appropriate prescribing of cyclooxygenase-2 (COX-2) inhibitors for 1,382 patients. Treatment with either a COX-2 or a traditional nonsteroidal anti-inflammatory drug (NSAID) was defined as appropriate or not according to three different definitions of gastrointestinal risk. Patients who saw or heard a COX-2 advertisement and asked their physician about the advertised drug were significantly more likely to be prescribed a COX-2 (versus a NSAID, as recommended by evidence-based guidelines) than all other patients. Findings also suggest that some patients may benefit from DTCA. The authors discuss the need for balanced drug information for consumers, increased physician vigilance in prescribing appropriately, and further study of DTCA.

Key Words: advertising • drug utilization • prescriptions • drugs • physician-patient relations


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Br. J. Ophthalmol.Home page
H. V Danesh-Meyer and L. A Levin
Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association?
Br. J. Ophthalmol., November 1, 2007; 91(11): 1551 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 Fam PractHome page
D Klein, A MacDonald, N Drummond, and A Cave
A qualitative study to identify factors influencing COXIB prescribed by family physicians for musculoskeletal disorders
Fam. Pract., December 1, 2006; 23(6): 659 - 665.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
B. L. Strom
How the US drug safety system should be changed.
JAMA, May 3, 2006; 295(17): 2072 - 2075.
[Full Text] [PDF]